Current News EV Biotech has partnered with Synonym to accelerate the development and commercialization of cutting-edge biomaterials Posted on February 14, 2024February 14, 2024 by Cort Meyerson 14 Feb Cort Meyerson Inherent Biosciences announced a comprehensive commercial partnership agreement with Genomic Prediction. This collaboration is set to advance male reproductive health by integrating Inherent Biosciences’ groundbreaking Epigenetic Sperm Quality Test (SpermQT™ marketed under the brand Path Fertility) into Genomic Prediction’s suite of clinical laboratory tests. California Cultured Inc. has agreed to 10-year partnership with Meiji, Japan’s largest chocolate company.
